Dr. Takeko Takeshige, DO

Dr. Takeshige practices at New Hyde Park Endoscopy in Lake Success, New York.

Dr. Takeshige's NPI, 1306998901, was assigned on January 17, 2007. Dr. Takeshige graduated from New York College of Osteo Medicine of New York Institute of Technology in 1996. Dr. Takeshige holds New York license 215907.

Dr. Takeshige's primary practice is New Hyde Park Endoscopy, at 1991 Marcus Avenue, Lake Success, NY 11042. The practice phone is (317) 796-7565.

Dr. Takeshige's primary practice is New Hyde Park Endoscopy in Lake Success, New York. Dr. Takeshige is also affiliated with North Shore University Hospital. The medical group on file is HSMF Women's Care. Dmand AI also links Dr. Takeshige to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Takeshige practices, 3 sites in all. Vendor and product names are available with a free account.

Obstetrics is Dr. Takeshige's primary specialty in the NPI Registry, under taxonomy code 207VX0000X. Dr. Takeshige is licensed in New York.

CMS data shows 664 Medicare services from Dr. Takeshige across 9 procedure codes in 2024, for 117 Medicare patients. Medicare paid $44,634 for them. Every service was in an office.

CMS counts 117 Medicare patients who saw Dr. Takeshige in 2024. The largest group is 65 to 74, with 64 patients. 75% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 0.91, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Takeshige's median patient age at 46, with 98% women.

In 2024, Dr. Takeshige wrote 130 Medicare Part D claims for 55 patients. 89% of them were for generic drugs. CMS names the drug for 66 of them, across 5 drugs with 11 or more claims each, at $2,059 in total drug cost. In 2023, CMS named 74 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Takeshige for performance year 2024, reported individually. Dr. Takeshige accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Takeshige as offering telehealth.

Dmand AI links 3 papers to Dr. Takeshige, published from 2018 to 2020. The most frequent topics are Physician-Patient Relations. Dr. Takeshige's most frequent co-authors are Umeko Takeshige, MD, Basem Z. Bernaba, MD and Mon-Lai Cheung, MD.

CMS Open Payments shows 54 general payments to Dr. Takeshige from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 87% of the total. Astellas Pharma US Inc paid the most, $379.

Dr. Takeshige graduated from New York College of Osteo Medicine of New York Institute of Technology in 1996.